Treatment News : Methadone Linked to Drop in HIV Rates Among Injection Drug Users

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » November 2012

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


November 5, 2012

Methadone Linked to Drop in HIV Rates Among Injection Drug Users

A major research review has found that injection drug users (IDUs) on methadone treatment are 54 percent less likely to contract HIV, according to a study published in the online edition of the British journal BMJ and reported in The New York Times.

The study was conducted by a group of researchers from the United Kingdom, Italy, the United States, Canada and Australia. The consortium analyzed a dozen published studies with information concerning opiate replacement therapy’s impact on HIV transmission; pooling data from nine of these studies, researchers identified 819 HIV infections spanning 23,000 person years.

The scientists suggested that the dramatic risk reduction was due to the fact that methadone improved drug users’ ability to adhere to HIV medications—which in turn reduced their likelihood of infecting others—and to refrain from sharing needles or from exchanging sex for drugs. However, given that those who commit to methadone treatment may also be more motivated toward risk-reducing behaviors, methadone on its own may not be the full cause of the 54 percent reduction.

The findings are vital, however, for efforts to push for opiate-replacement programs in countries such as Russia where injection drug use is rampant and is a major driver of new HIV infections, but where methadone remains illegal.

For the New York Times story, click here.

For a PDF of the research paper, click here.

Search: HIV, methadone, opiate replacement therapy, drop in infection rates, injection drug users, IDU, BMJ, The New York Times

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.